Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $20 million

http://www.colorforth.com/MoorevsTPL.pdf

Line 8, page 9.

I stand corrected.

Moores' cut, after TPL and PTSC joined their halves of the MMP, is 55% of TPLs' half, after TPL takes the first 15% of the total net revenue for litigation expenses.

Mike, you are right. PTSC should not be liable for restitution to Moore.

Share
New Message
Please login to post a reply